Ingvild L. Tangen

2.6k total citations
26 papers, 684 citations indexed

About

Ingvild L. Tangen is a scholar working on Obstetrics and Gynecology, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Ingvild L. Tangen has authored 26 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Obstetrics and Gynecology, 12 papers in Molecular Biology and 12 papers in Reproductive Medicine. Recurrent topics in Ingvild L. Tangen's work include Endometrial and Cervical Cancer Treatments (15 papers), Ovarian cancer diagnosis and treatment (11 papers) and Estrogen and related hormone effects (5 papers). Ingvild L. Tangen is often cited by papers focused on Endometrial and Cervical Cancer Treatments (15 papers), Ovarian cancer diagnosis and treatment (11 papers) and Estrogen and related hormone effects (5 papers). Ingvild L. Tangen collaborates with scholars based in Norway, United States and Netherlands. Ingvild L. Tangen's co-authors include Camilla Krakstad, Jone Trovik, Helga B. Salvesen, Mari K. Halle, Anna Berg, Erling A. Høivik, Kanthida Kusonmano, Anne M. Øyan, Henrica M.J. Werner and Ingfrid S. Haldorsen and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Cell Science.

In The Last Decade

Ingvild L. Tangen

26 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ingvild L. Tangen Norway	17	326	257	200	180	145	26	684
Henrica M.J. Werner Norway	13	431 1.3×	171 0.7×	271 1.4×	114 0.6×	120 0.8×	21	680
Andrew Berchuck United States	10	157 0.5×	560 2.2×	268 1.3×	375 2.1×	203 1.4×	11	1.1k
Jessica C. Price United States	7	139 0.4×	368 1.4×	101 0.5×	119 0.7×	145 1.0×	8	551
Rebecca J. Wolsky United States	8	275 0.8×	223 0.9×	216 1.1×	121 0.7×	89 0.6×	21	624
Tuomas Heikkinen Finland	16	135 0.4×	517 2.0×	118 0.6×	200 1.1×	239 1.6×	30	876
Jieqing Zhang China	11	68 0.2×	242 0.9×	111 0.6×	96 0.5×	89 0.6×	36	490
Kety Huberman United States	9	96 0.3×	364 1.4×	112 0.6×	302 1.7×	289 2.0×	13	847
Anna S. Nam United States	10	95 0.3×	274 1.1×	111 0.6×	112 0.6×	165 1.1×	17	565
Susanne Malander Sweden	16	89 0.3×	291 1.1×	537 2.7×	497 2.8×	187 1.3×	44	1.0k
Cindy A. Pise-Masison United States	5	65 0.2×	497 1.9×	371 1.9×	158 0.9×	320 2.2×	6	820

Countries citing papers authored by Ingvild L. Tangen

Since Specialization

Citations

This map shows the geographic impact of Ingvild L. Tangen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingvild L. Tangen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingvild L. Tangen more than expected).

Fields of papers citing papers by Ingvild L. Tangen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingvild L. Tangen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingvild L. Tangen. The network helps show where Ingvild L. Tangen may publish in the future.

Co-authorship network of co-authors of Ingvild L. Tangen

This figure shows the co-authorship network connecting the top 25 collaborators of Ingvild L. Tangen. A scholar is included among the top collaborators of Ingvild L. Tangen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingvild L. Tangen. Ingvild L. Tangen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Karlsson, Thomas, et al.. (2021). Nuclear upregulation of class I phosphoinositide 3-kinase p110β correlates with high 47S rRNA levels in cancer cells. Journal of Cell Science. 134(3). 6 indexed citations

Strand, Elin, Ingvild L. Tangen, Kristine E. Fasmer, et al.. (2019). Blood Metabolites Associate with Prognosis in Endometrial Cancer. Metabolites. 9(12). 302–302. 13 indexed citations

Tangen, Ingvild L., Mari K. Halle, Kristin Viste, et al.. (2019). Blood steroid levels predict survival in endometrial cancer and reflect tumor estrogen signaling. Gynecologic Oncology. 156(2). 400–406. 11 indexed citations

Weelden, Willem Jan van, Kristine E. Fasmer, Ingvild L. Tangen, et al.. (2019). Impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma: a retrospective study. BMC Cancer. 19(1). 16 indexed citations

Berg, Hege F., Kristine E. Fasmer, Ingvild L. Tangen, et al.. (2019). Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer. PLoS ONE. 14(1). e0210585–e0210585. 7 indexed citations

Kusonmano, Kanthida, Mari K. Halle, Elisabeth Wik, et al.. (2018). Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer. PLoS ONE. 13(11). e0206665–e0206665. 9 indexed citations

Tangen, Ingvild L., Kristine E. Fasmer, Arthur Jochems, et al.. (2018). Blood steroids are associated with prognosis and fat distribution in endometrial cancer. Gynecologic Oncology. 152(1). 46–52. 14 indexed citations

Halle, Mari K., Akinyemi I. Ojesina, Kathrine Woie, et al.. (2017). Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study. American Journal of Obstetrics and Gynecology. 217(4). 432.e1–432.e17. 40 indexed citations

Tangen, Ingvild L., Jennifer Veneris, Mari K. Halle, et al.. (2017). Expression of glucocorticoid receptor is associated with aggressive primary endometrial cancer and increases from primary to metastatic lesions. Gynecologic Oncology. 147(3). 672–677. 18 indexed citations

10.

Fasmer, Kristine E., Atle Bjørnerud, Sigmund Ytre‐Hauge, et al.. (2017). Preoperative quantitative dynamic contrast-enhanced MRI and diffusion-weighted imaging predict aggressive disease in endometrial cancer. Acta Radiologica. 59(8). 1010–1017. 36 indexed citations

11.

Halle, Mari K., Ingvild L. Tangen, Hege F. Berg, et al.. (2017). HER2 expression patterns in paired primary and metastatic endometrial cancer lesions. British Journal of Cancer. 118(3). 378–387. 57 indexed citations

12.

Berg, Anna, Sigmund Ytre‐Hauge, Kristine E. Fasmer, et al.. (2017). Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers. Oncotarget. 8(40). 68530–68541. 4 indexed citations

13.

Berg, Hege F., Per‐Henrik Edqvist, Anna Berg, et al.. (2017). Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions. Gynecologic Oncology. 148(1). 197–203. 16 indexed citations

14.

Mjøs, Siv, Henrica M.J. Werner, Even Birkeland, et al.. (2017). PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer. Scientific Reports. 7(1). 10240–10240. 23 indexed citations

15.

Karlsson, Thomas, Camilla Krakstad, Ingvild L. Tangen, et al.. (2016). Endometrial cancer cells exhibit high expression of p110β and its selective inhibition induces variable responses on PI3K signaling, cell survival and proliferation. Oncotarget. 8(3). 3881–3894. 11 indexed citations

16.

Tangen, Ingvild L., Reidun Kopperud, Anna Berg, et al.. (2016). Androgen receptor as potential therapeutic target in metastatic endometrial cancer. Oncotarget. 7(31). 49289–49298. 56 indexed citations

17.

Tangen, Ingvild L., Camilla Krakstad, Mari K. Halle, et al.. (2014). Switch in FOXA1 Status Associates with Endometrial Cancer Progression. PLoS ONE. 9(5). e98069–e98069. 20 indexed citations

18.

Tangen, Ingvild L., Henrica M.J. Werner, Anna Berg, et al.. (2014). Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesions. European Journal of Cancer. 50(17). 3003–3010. 61 indexed citations

19.

Tangen, Ingvild L., Sören Berg, Kanthida Kusonmano, et al.. (2014). High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors. British Journal of Cancer. 111(1). 78–84. 49 indexed citations

20.

Werner, Henrica M.J., Jone Trovik, Mari K. Halle, et al.. (2014). Stathmin Protein Level, a Potential Predictive Marker for Taxane Treatment Response in Endometrial Cancer. PLoS ONE. 9(2). e90141–e90141. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact